Literature DB >> 8375452

Osteoblast function and osteomalacia in metastatic prostate cancer.

N W Clarke1, J McClure, N J George.   

Abstract

This study has examined the effect of prostate cancer on bone matrix formation and mineralisation by osteoblasts, with special reference to osteomalacia. Sixty-seven patients with prostatic bone metastases underwent transiliac bone biopsy after double tetracycline labelling. Histomorphometric analysis was then undertaken in areas distant from, local to and infiltrated by prostate cancer. In bone free of tumour (n = 45) and bone surrounding metastases (n = 7) both matrix formation and corrected mineral apposition rate were low. By comparison osteoid surface, osteoid volume and mineral apposition rate were markedly increased within metastases (tumor-free bone vs. metastatic bone, p < 0.0001), a finding consistent with a high bone turnover state. Although osteoblast function was disturbed both within metastases and in tumour-free areas, classical osteomalacia was not associated with prostate cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8375452     DOI: 10.1159/000474311

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  21 in total

Review 1.  Treatment and prevention of bone complications from prostate cancer.

Authors:  Richard J Lee; Philip J Saylor; Matthew R Smith
Journal:  Bone       Date:  2010-05-31       Impact factor: 4.398

Review 2.  Contemporary therapeutic approaches targeting bone complications in prostate cancer.

Authors:  Richard J Lee; Philip J Saylor; Matthew R Smith
Journal:  Clin Genitourin Cancer       Date:  2010-12-01       Impact factor: 2.872

Review 3.  Emerging therapies to prevent skeletal morbidity in men with prostate cancer.

Authors:  Philip J Saylor; Richard J Lee; Matthew R Smith
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

Review 4.  Implications of the Fracture Risk Assessment Algorithm for the assessment and improvement of bone health in patients with prostate cancer: A comprehensive review.

Authors:  Ashish Sharma; Rahul Janak Sinha; Vishwajeet Singh; Gaurav Garg; Samarth Agarwal; Siddharth Pandey
Journal:  Turk J Urol       Date:  2019-02-20

Review 5.  Bone health and prostate cancer.

Authors:  P J Saylor; M R Smith
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-11-10       Impact factor: 5.554

Review 6.  Molecular mechanisms of metastasis in prostate cancer.

Authors:  Noel W Clarke; Claire A Hart; Mick D Brown
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

Review 7.  Targeting bone physiology for the treatment of metastatic prostate cancer.

Authors:  Karen A Autio; Michael J Morris
Journal:  Clin Adv Hematol Oncol       Date:  2013-03

Review 8.  Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer.

Authors:  Richard J Lee; Matthew R Smith
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

Review 9.  New and emerging therapies for bone metastases in genitourinary cancers.

Authors:  Philip J Saylor; Andrew J Armstrong; Karim Fizazi; Stephen Freedland; Fred Saad; Matthew R Smith; Bertrand Tombal; Kenneth Pienta
Journal:  Eur Urol       Date:  2012-11-23       Impact factor: 20.096

10.  Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation.

Authors:  Ronald R Gomes; Patricia Buttke; Emmanuel M Paul; Robert A Sikes
Journal:  Clin Exp Metastasis       Date:  2009-05-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.